Evolution of surfactant protein-D levels in children with ventilator-associated pneumonia

Pediatric Pulmonology

Volumn 47, Issue 3, 2012, Pages 292-299

  Said, Ahmed S ^a,b   Abd Elaziz, Manal M ^a   Farid, Mohamed M ^a   Abd Elfattah, Magid A ^a   Abdel Monim, Mahmoud T ^a   Doctor, Allan ^b,c  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

clinical pulmonary infection score; nosocomial; surfactant protein D

Indexed keywords

SURFACTANT PROTEIN D;

AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL ARTICLE; CLINICAL PULMONARY INFECTION SCORE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INTUBATION; KLEBSIELLA PNEUMONIAE; LUNG LAVAGE; MALE; MOLECULAR EVOLUTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; PSEUDOMONAS AERUGINOSA; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS; VENTILATOR ASSOCIATED PNEUMONIA;

ADOLESCENT; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; EGYPT; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LONGITUDINAL STUDIES; MALE; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84857355350     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21548     Document Type: Article

References (45)

1. Mayhall CG,. Ventilator-associated pneumonia or not? Contemporary diagnosis. Emerg Infect Dis 2001; 7: 200-204. (Pubitemid 32374328)
2. Strausbaugh L,. Nosocomial respiratory infections. In:, Mandell G, Bennett J, Dolin R, editors. Principles and practice of infectious diseases. Volume 5th. PA: Churchill Livingstone; 2000. pp. 3020-3027.
3. Chastre J, Fagon JY,. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165: 867-903. (Pubitemid 34774654)
4. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004; issued October 2004. Am J Infect Control 2004; 32: 470-485.
5. Stover BH, Shulman ST, Bratcher DF, Brady MT, Levine GL, Jarvis WR,. Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control 2001; 29: 152-157. (Pubitemid 32507079)
6. Apostolopoulou E, Bakakos P, Katostaras T, Gregorakos L,. Incidence and risk factors for ventilator-associated pneumonia in 4 multidisciplinary intensive care units in Athens, Greece. Respir Care 2003; 48: 681-688.
7. Almuneef M, Memish ZA, Balkhy HH, Alalem H, Abutaleb A,. Ventilator-associated pneumonia in a pediatric intensive care unit in Saudi Arabia: A 30-month prospective surveillance. Infect Control Hosp Epidemiol 2004; 25: 753-758. (Pubitemid 39312047)
8. El-Nawawy AA, Abd El-Fattah MM, Metwally HA, Barakat SS, Hassan IA,. One year study of bacterial and fungal nosocomial infections among patients in pediatric intensive care unit (PICU) in Alexandria. J Trop Pediatr 2006; 52: 185-191. (Pubitemid 43997455)
9. Bigham MT, Amato R, Bondurrant P, Fridriksson J, Krawczeski CD, Raake J, Ryckman S, Schwartz S, Shaw J, Wells D, et al. Ventilator-associated pneumonia in the pediatric intensive care unit: Characterizing the problem and implementing a sustainable solution. J Pediatr 2009; 154: 582-587 e582.
10. Srinivasan R, Asselin J, Gildengorin G, Wiener-Kronish J, Flori HR,. A prospective study of ventilator-associated pneumonia in children. Pediatrics 2009; 123: 1108-1115.
11. Fartoukh M, Maitre B, Honore S, Cerf C, Zahar JR, Brun-Buisson C,. Diagnosing pneumonia during mechanical ventilation: The clinical pulmonary infection score revisited. Am J Respir Crit Care Med 2003; 168: 173-179. (Pubitemid 36920970)
12. Rea-Neto A, Youssef NC, Tuche F, Brunkhorst F, Ranieri VM, Reinhart K, Sakr Y,. Diagnosis of ventilator-associated pneumonia: A systematic review of the literature. Crit Care 2008; 12: R56.
13. Sole Violan J, Fernandez JA, Benitez AB, Cardenosa Cendrero JA, Rodriguez deCastro F,. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med 2000; 28: 2737-2741.
14. Heyland D, Ewig S, Torres A,. Pro/con clinical debate: The use of a protected specimen brush in the diagnosis of ventilator associated pneumonia. Crit Care 2002; 6: 117-120. (Pubitemid 34296338)
15. Rennard SI, Aalbers R, Bleecker E, Klech H, Rosenwasser L, Olivieri D, Sibille Y,. Bronchoalveolar lavage: Performance, sampling procedure, processing and assessment. Eur Respir J Suppl 1998; 26: 13S-15S. (Pubitemid 28184037)
16. Johanson WG, Jr, Pierce AK, Sanford JP, Thomas GD,. Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med 1972; 77: 701-706.
17. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM,. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143: 1121-1129.
18. Rosbolt MB, Sterling ES, Fahy BG,. The utility of the clinical pulmonary infection score. J Intensive Care Med 2009; 24: 26-34.
19. CDC, National Safety Healthcare, Network, Protocols and Modules, Device Associated Module, Ventilator Associated Pneumonia. Volume 2010; 2010.
20. Stewart N, Cuthbertson B,. The problems diagnosing ventilator-associated pneumonia. J Intensive Care Soc 2009; 10: 266-272.
21. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, Kim KS, McCormack FX,. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 2003; 111: 1589-1602. (Pubitemid 38063292)
22. Malloy JL, Veldhuizen RA, Lewis JF,. Effects of ventilation on the surfactant system in sepsis-induced lung injury. J Appl Physiol 2000; 88: 401-408. (Pubitemid 30097080)
23. Griese M, Steinecker M, Schumacher S, Braun A, Lohse P, Heinrich S,. Children with absent surfactant protein D in bronchoalveolar lavage have more frequently pneumonia. Pediatr Allergy Immunol 2008; 19: 639-647.
24. Kolsuz M, Erginel S, Alatas O, Alatas F, Metintas M, Ucgun I, Harmanci E, Colak O,. Acute phase reactants and cytokine levels in unilateral community-acquired pneumonia. Respiration 2003; 70: 615-622. (Pubitemid 38142314)
25. Ratjen F, Havers W, Braun J,. Intrapulmonary protein leakage in immunocompromised children and adults with pneumonia. Thorax 1999; 54: 432-436. (Pubitemid 29199783)
26. Moore DS, McCabe GP, editors. Introduction to the practice of statistics, 2nd edition. New York: W. H. Freeman and Company; 1993.
27. Zweig MH, Campbell G,. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-577. (Pubitemid 23118304)
28. Torres A, Aznar R, Gatell JM, Jimenez P, Gonzalez J, Ferrer A, Celis R, Rodriguez-Roisin R,. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990; 142: 523-528. (Pubitemid 20292709)
29. Langer M, Mosconi P, Cigada M, Mandelli M,. Long-term respiratory support and risk of pneumonia in critically ill patients. Intensive Care Unit Group of Infection Control. Am Rev Respir Dis 1989; 140: 302-305. (Pubitemid 19218339)
30. Celis R, Torres A, Gatell JM, Almela M, Rodriguez-Roisin R, Agusti-Vidal A,. Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest 1988; 93: 318-324. (Pubitemid 18053068)
31. Fagon JY, Chastre J, Domart Y, Trouillet JL, Pierre J, Darne C, Gibert C,. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989; 139: 877-884. (Pubitemid 19094308)
32. Atochina EN, Beers MF, Scanlon ST, Preston AM, Beck JM,. P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant. Am J Physiol Lung Cell Mol Physiol 2000; 278: L599-L609. (Pubitemid 30152518)
33. Olesen HV, Holmskov U, Schiotz PO, Sorensen GL,. Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis. J Cyst Fibros 2010; 9: 257-262.
34. Crouch E, Wright JR,. Surfactant proteins a and d and pulmonary host defense. Annu Rev Physiol 2001; 63: 521-554. (Pubitemid 32304328)
35. Reid KB,. Interactions of surfactant protein D with pathogens, allergens and phagocytes. Biochim Biophys Acta 1998; 1408: 290-295. (Pubitemid 28517873)
36. Bufler P, Schikor D, Schmidt B, Griese M,. Cytokine stimulation by Pseudomonas aeruginosa-strain variation and modulation by pulmonary surfactant. Exp Lung Res 2004; 30: 163-179. (Pubitemid 38402441)
37. Bufler P, Schmidt B, Schikor D, Bauernfeind A, Crouch EC, Griese M,. Surfactant protein A and D differently regulate the immune response to nonmucoid Pseudomonas aeruginosa and its lipopolysaccharide. Am J Respir Cell Mol Biol 2003; 28: 249-256. (Pubitemid 36169655)
38. Restrepo CI, Dong Q, Savov J, Mariencheck WI, Wright JR,. Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages. Am J Respir Cell Mol Biol 1999; 21: 576-585. (Pubitemid 129586593)
39. Faure K, Leberre R, Guery B,. [Pseudomonas aeruginosa and Surfactant-associated proteins A and D]. Med Mal Infect 2006; 36: 63-71.
40. Alcorn JF, Wright JR,. Degradation of pulmonary surfactant protein D by Pseudomonas aeruginosa elastase abrogates innate immune function. J Biol Chem 2004; 279: 30871-30879. (Pubitemid 38938023)
41. Malloy JL, Veldhuizen RA, Thibodeaux BA, O'Callaghan RJ, Wright JR,. Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. Am J Physiol Lung Cell Mol Physiol 2005; 288: L409-L418. (Pubitemid 40105381)
42. Beatty AL, Malloy JL, Wright JR,. Pseudomonas aeruginosa degrades pulmonary surfactant and increases conversion in vitro. Am J Respir Cell Mol Biol 2005; 32: 128-134. (Pubitemid 40189694)
43. von Bredow C, Wiesener A, Griese M,. Proteolysis of surfactant protein D by cystic fibrosis relevant proteases. Lung 2003; 181: 79-88. (Pubitemid 37026548)
44. Smith L, Rose B, Tingpej P, Zhu H, Conibear T, Manos J, Bye P, Elkins M, Willcox M, Bell S, et al. Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis. J Med Microbiol 2006; 55: 1641-1644. (Pubitemid 44902025)
45. Starosta V, Griese M,. Oxidative damage to surfactant protein D in pulmonary diseases. Free Radic Res 2006; 40: 419-425. (Pubitemid 43336047)